| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |